iShares Dow Jones US Pharm Ind - IHE - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

iShares Dow Jones US Pharm Ind - SIC # 6722

Ticker	Exchange	SIC #	Website	Latest Ticker
IHE	New York	6722	http://www.iShares.com	103.4099 +0.7899
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for iShares Dow Jones US Pharm Ind Low Expense Top Performing ETFs - Jun 12th, 2013 11:00 am Celgene Soars in 2013; What Does the Future Hold? - Jun 6th, 2013 11:19 am Which Pharmaceutical ETF Is Leading In Inflows? PJP vs. IHE vs. XPH - Jun 6th, 2013 5:00 am Top 10 Healthcare Sector ETFs - May 30th, 2013 11:30 am IHE, PFE, AGN, ACT: Large Outflows Detected At ETF - May 10th, 2013 9:01 am Abbott: Where Is Growth Coming From? - Apr 22nd, 2013 2:09 pm iShares Dow Jones U.S. Pharmaceuticals Index Fund Experiences Big Inflow - Apr 16th, 2013 9:01 am The Best Pharmaceutical Investments - Mar 20th, 2013 1:01 pm PowerShares Dynamic Pharmaceuticals ETF: Big Pharma Looks Abroad to Continue Its Run - Mar 11th, 2013 9:45 am ETF Investors Need To Keep An Eye On These 3 Longer-Term Trends - Feb 25th, 2013 3:53 pm ETFs Worth Considering... Even After The S&P 500's 7-Week Streak - Feb 15th, 2013 4:26 pm Domestic ETF Risk-Taking Vibrant, International ETF Risk-Taking Constrained - Feb 11th, 2013 2:20 pm Balchunas on the Gains in Pharmaceutical ETFs (Audio) - Feb 4th, 2013 6:57 pm iShares Dow Jones U.S. Pharmaceuticals Index Fund Experiences Big Outflow - Jan 24th, 2013 9:34 am iShares Dow Jones U.S. Pharmaceuticals Index Fund Breaks Above 200-Day Moving Average - Bullish for IHE - Jan 2nd, 2013 10:08 am 9 ETFs to Help Diversify Your Portfolio in 2013 - Dec 15th, 2012 10:32 am IHE, PFE, BMY, LLY: Large Outflows Detected at ETF - Dec 5th, 2012 10:34 am Noteworthy ETF Outflows: IHE - Nov 7th, 2012 9:37 am 30 Million New Health Insurance Buyers Will Drive Selected Health Care Stocks: Experienced Sector Analyst Details the Benefits from an Obama Victory - Nov 7th, 2012 5:39 am Vote For Obama Or Romney With These ETFs - Nov 2nd, 2012 7:00 am View All Current Headlines >>